分期完成性胰腺切除与单期全胰腺切除的远期内分泌后遗症比较
本研究比较单期全胰腺切除与两期完成性胰腺切除患者的内分泌结局。多机构网络分析匹配1079对患者,全胰腺切除组术后第一年内分泌并发症风险增加2.9倍,低血糖风险增加3.0倍,糖尿病酮症酸中毒风险增加9.3倍。单中心验证亦显示全胰腺切除组低血糖风险更高(HR 3.9)。
要点
- 全胰腺切除患者术后第一年内分泌并发症风险显著高于完成性胰腺切除。
- 全胰腺切除组低血糖和糖尿病酮症酸中毒风险均显著增加。
- 对全胰腺切除患者需加强术后血糖监测和患者教育。
核心结论
- 两期完成性胰腺切除患者的内分泌并发症少于单期全胰腺切除患者。
研究设计与样本
- 多机构研究网络(TriNetX)倾向性评分匹配1079对全胰腺切除与完成性胰腺切除患者,并按年龄、性别、种族匹配。
- 单中心验证:回顾性分析2013至2023年间前瞻性维护数据库中的1600例胰腺切除患者,识别出88例完成性或全胰腺切除患者。
主要发现
- 网络分析中,全胰腺切除组术后第一年内分泌并发症风险为完成性胰腺切除组的2.9倍(HR 2.9,95%CI 2.2-3.7,P < .00001)。
- 全胰腺切除组低血糖风险增加(HR 3.0,95%CI 2.2-4.0,P < .00001),糖尿病酮症酸中毒风险增加(HR 9.3,95%CI 4.0-21.7,P < .0001)。
- 单中心分析中,全胰腺切除组低血糖发生率是完成性胰腺切除组的3.9倍(HR 3.9,95%CI 1.2-13.0,P = .025)。
- Kaplan-Meier分析显示全胰腺切除患者低血糖事件发生更早且更频繁(多机构队列P < .00001,单中心验证队列P < .01)。
临床怎么用
- 对于全胰腺切除患者,术后第一年应加强血糖监测和患者教育以早期发现内分泌并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total pancreatectomy can be associated with severe endocrine complications. This study compares endocrine outcomes of patients who underwent a single-stage total pancreatectomy versus a 2-stage completion pancreatectomy. METHODS: We used data from a multi-institutional research network (TriNetX), which identified 1,079 propensity score-matched total pancreatectomy and completion pancreatectomy patient pairs for age, gender, and race. These data were validated by a single-center review of a prospectively maintained database of 1,600 pancreatectomies, from which 88 completion and total pancreatectomy patients treated between 2013 and 2023 were identified. The primary endpoints were postoperative rates of hypoglycemia and diabetic ketoacidosis during the first year following surgery. RESULTS: The network analysis identified 1,079 propensity score-matched total pancreatectomy and completion pancreatectomy pairs with similar demographics. During the first year following the surgery, patients in the total pancreatectomy cohort had a 2.9-fold increased risk of endocrine complications compared with the completion pancreatectomy cohort (hazard ratio 2.9, 95% confidence interval 2.2-3.7, P < .00001). Total pancreatectomy patients had an increased risk of hypoglycemia (hazard ratio 3.0, 95% confidence interval 2.2-4.0, P < .00001) and an increased risk of diabetic ketoacidosis (hazard ratio 9.3, 95% confidence interval 4.0-21.7, P < .0001). In the single-center analysis, total pancreatectomy patients showed a 3.9-fold (hazard ratio 3.9, 95% confidence interval 1.2-13.0, P = .025) higher hypoglycemia rate than completion pancreatectomy patients. Kaplan-Meier analyses demonstrated that total pancreatectomy patients experienced earlier and more frequent hypoglycemic events compared with completion pancreatectomy patients both in the multi-institutional cohort (P < .00001) and in the single-center validation cohort (P < .01). CONCLUSIONS: Our findings indicate that 2-stage completion pancreatectomy patients experience fewer endocrine complications than total pancreatectomy patients. The higher early postoperative endocrine complication rates in total pancreatectomy patients underscore the need for vigilant monitoring and improved patient education in this patient cohort.
引用
- Chang ML, Kraft M, Kaplan Z, et al. Assessment of long-term endocrine sequelae of completion (2-stage) versus total (single-stage) pancreatectomy: A multi-institutional research network and single-institution analysis. Surgery. 2025. PMID: 41138542. doi:10.1016/j.surg.2025.109830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。